Update on the Colon Health and Life-Long Exercise Change Trial: A Phase III Study of the Impact of an Exercise Program on Disease-Free Survival in Colon Cancer Survivors
Kerry S. Courneya , Janette Vardy , Sharlene Gill , Derek Jonker
Current Colorectal Cancer Reports 10 ( 3) 321 -328
25
2014
New developments in therapy for metastatic colorectal cancer
Sharlene Gill
Current Colorectal Cancer Reports 1 ( 1) 13 -17
2005
Individual data pooled analyses to improve understanding of adjuvant therapy in colon cancer: Review of the ACCENT collaborative group
Sharlene Gill , Daniel J. Sargent
Current Colorectal Cancer Reports 4 ( 3) 155 -159
1
2008
Efficacy and prognostic factors for y-90 radioembolization (Y-90) in metastatic neuroendocrine tumors with liver metastases.
Erica S Tsang , Jonathan M. Loree , Janine Marie Davies , Sharlene Gill
Journal of Clinical Oncology 36 ( 15_suppl) e16180 -e16180
2018
Adjuvant chemotherapy and survival outcomes in diabetic patients with colon cancer: A population-based analysis.
Shiru Lucy Liu , Sharlene Gill , Winson Y. Cheung
Journal of Clinical Oncology 36 3589 -3589
2018
Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
Gillian K Gresham , George A Wells , Sharlene Gill , Christopher Cameron
BMC Cancer 14 ( 1) 471 -471
78
2014
Role of cyclooxygenase-2 in colorectal cancer
Frank A. Sinicrope , Sharlene Gill
Cancer and Metastasis Reviews 23 ( 1/2) 63 -75
285
2004
Hepatic dysfunction during and after lymphoma chemotherapy in patients with hepatitis C.
Justin Shah , Eric M. Yoshida , Joseph Connors , Sharlene Gill
Journal of Clinical Gastroenterology 40 ( 7) 636 -638
2006
Abstract PO-016: Evaluating the impact of COVID-19 on medical oncology workforce and cancer care in Canada: A serial survey study
Sharlene Gill , Bruce Colwell , Hal Hirte , Welch Stephen
Clinical Cancer Research 26
2020
A population-based analysis of outcomes in cancer patients who do not satisfy clinical trial eligibility criteria (CTEC).
Winson Y. Cheung , Hagen F. Kennecke , Howard John Lim , Daniel John Renouf
Journal of Clinical Oncology 31 6502 -6502
2013
Adjuvant chemotherapy (AC) outcomes in young (YP) and elderly patients (EP) with high-risk stage II colon cancer (CC).
Aalok Kumar , Hagen F. Kennecke , Howard John Lim , Daniel John Renouf
Journal of Clinical Oncology 31 3569 -3569
2013
Impact of M1a and M1b staging in patients (pts) with metastatic colorectal cancer.
Hagen F. Kennecke , Jason Yu , Sharlene Gill , Winson Y. Cheung
Journal of Clinical Oncology 31 3590 -3590
1
2013
Guanylyl cyclase C (GCC) expression in lymph nodes (LNs) as a determinant of recurrence in stage II colon cancer (CC) patients (pts).
Daniel J. Sargent , Qian Shi , Sharlene Gill , Christophe Louvet
Journal of Clinical Oncology 31 3639 -3639
2013
A network meta-analysis (NMA) of randomized controlled trials (RCT) of chemotherapy regimens for metastatic pancreatic cancer (mPC).
Gillian Gresham , Sharlene Gill , George A Wells , Derek J. Jonker
Journal of Clinical Oncology 31 4050 -4050
2
2013
The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: A multicenter retrospective analysis.
Suganija Lakkunarajah , Daniel Adam Breadner , Hanbo Zhang , Jennifer L. Spratlin
Journal of Clinical Oncology 38 248 -248
2020
Eligibility for second-line therapy in patients with advanced hepatocellular carcinoma (aHCC): A BC Cancer population-based study.
Erica S. Tsang , Janine Marie Davies , Jonathan M. Loree , Howard John Lim
Journal of Clinical Oncology 38 491 -491
2020
Clinical and pathologic characteristics of early-onset colorectal cancer (EoCRC).
Arif Ahmad Arif , Daljeet Chahal , Caroline Speers , Sharlene Gill
Journal of Clinical Oncology 38 72 -72
2020
Patterns of diagnosis for colorectal cancer: screening detected vs. symptomatic presentation.
Sasha Smiljanic , Sharlene Gill
Diseases of The Colon & Rectum 51 ( 5) 573 -577
10
2008
Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience.
David A. Schomas , Robert C. Miller , John H. Donohue , Sharlene Gill
Annals of Surgery 249 ( 4) 588 -595
15
2009
Effect of M1a and M1b Category in Metastatic Colorectal Cancer
Hagen Kennecke , Jason Yu , Sharlene Gill , Winson Y. Cheung
Oncologist 19 ( 7) 720 -726
15
2014